ADORA2A and pancreatic adenocarcinoma: Analysis of RNA-sequencing data of pancreatic adenocarcinoma (TCGA, Provisional) revealed that a low expression of ADORA2A, which encodes the A2A adenosine receptor, was associated with poor overall survival and disease-free survival (Figure 8A,B; log-rank P = 0.0302 and P = 0.0104, respectively).